Modeling neuropsychiatric disorders using human induced pluripotent stem cells

ABSTRACT Neuropsychiatric disorders are complex disorders characterized by heterogeneous genetic variations, variable symptoms, and widespread changes in anatomical pathology. In the context of neuropsychiatric disorders, limited access to relevant tissue types presents challenges for understanding...

Full description

Bibliographic Details
Main Authors: Meiyan Wang, Lei Zhang, Fred H. Gage
Format: Article
Language:English
Published: SpringerOpen 2019-05-01
Series:Protein & Cell
Subjects:
Online Access:http://link.springer.com/article/10.1007/s13238-019-0638-8
id doaj-283ddeaf6eda4d5f98b898dc6845e6ee
record_format Article
spelling doaj-283ddeaf6eda4d5f98b898dc6845e6ee2020-11-25T03:07:54ZengSpringerOpenProtein & Cell1674-800X1674-80182019-05-01111455910.1007/s13238-019-0638-8Modeling neuropsychiatric disorders using human induced pluripotent stem cellsMeiyan Wang0Lei Zhang1Fred H. Gage2Laboratory of Genetics, The Salk Institute for Biological StudiesLaboratory of Genetics, The Salk Institute for Biological StudiesLaboratory of Genetics, The Salk Institute for Biological StudiesABSTRACT Neuropsychiatric disorders are complex disorders characterized by heterogeneous genetic variations, variable symptoms, and widespread changes in anatomical pathology. In the context of neuropsychiatric disorders, limited access to relevant tissue types presents challenges for understanding disease etiology and developing effective treatments. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an opportunity to recapitulate disease development in relevant cell types, and they provide novel approaches for understanding disease mechanisms and for development of effective treatments. Here we review recent progress and challenges in differentiation paradigms for generating disease-relevant cells and recent studies of neuropsychiatric disorders using human pluripotent stem cell (hPSC) models where cellular phenotypes linked to disease have been reported. The use of iPSC-based disease models holds great promise for understanding disease mechanisms and supporting discovery of effective treatments.http://link.springer.com/article/10.1007/s13238-019-0638-8neuropsychiatric disordersiPSCsbrain organoidschizophreniaautism spectrum disorderbipolar disorder
collection DOAJ
language English
format Article
sources DOAJ
author Meiyan Wang
Lei Zhang
Fred H. Gage
spellingShingle Meiyan Wang
Lei Zhang
Fred H. Gage
Modeling neuropsychiatric disorders using human induced pluripotent stem cells
Protein & Cell
neuropsychiatric disorders
iPSCs
brain organoid
schizophrenia
autism spectrum disorder
bipolar disorder
author_facet Meiyan Wang
Lei Zhang
Fred H. Gage
author_sort Meiyan Wang
title Modeling neuropsychiatric disorders using human induced pluripotent stem cells
title_short Modeling neuropsychiatric disorders using human induced pluripotent stem cells
title_full Modeling neuropsychiatric disorders using human induced pluripotent stem cells
title_fullStr Modeling neuropsychiatric disorders using human induced pluripotent stem cells
title_full_unstemmed Modeling neuropsychiatric disorders using human induced pluripotent stem cells
title_sort modeling neuropsychiatric disorders using human induced pluripotent stem cells
publisher SpringerOpen
series Protein & Cell
issn 1674-800X
1674-8018
publishDate 2019-05-01
description ABSTRACT Neuropsychiatric disorders are complex disorders characterized by heterogeneous genetic variations, variable symptoms, and widespread changes in anatomical pathology. In the context of neuropsychiatric disorders, limited access to relevant tissue types presents challenges for understanding disease etiology and developing effective treatments. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an opportunity to recapitulate disease development in relevant cell types, and they provide novel approaches for understanding disease mechanisms and for development of effective treatments. Here we review recent progress and challenges in differentiation paradigms for generating disease-relevant cells and recent studies of neuropsychiatric disorders using human pluripotent stem cell (hPSC) models where cellular phenotypes linked to disease have been reported. The use of iPSC-based disease models holds great promise for understanding disease mechanisms and supporting discovery of effective treatments.
topic neuropsychiatric disorders
iPSCs
brain organoid
schizophrenia
autism spectrum disorder
bipolar disorder
url http://link.springer.com/article/10.1007/s13238-019-0638-8
work_keys_str_mv AT meiyanwang modelingneuropsychiatricdisordersusinghumaninducedpluripotentstemcells
AT leizhang modelingneuropsychiatricdisordersusinghumaninducedpluripotentstemcells
AT fredhgage modelingneuropsychiatricdisordersusinghumaninducedpluripotentstemcells
_version_ 1724668553603317760